Sirolimus-induced regression of a large orbital lymphangioma.
Orbit
; 38(1): 79-80, 2019 Feb.
Article
em En
| MEDLINE
| ID: mdl-29405800
ABSTRACT
Microcystic lymphatic malformations are difficult to treat surgically, especially when located in the orbital apex. Recently, pharmacologic inhibition of the mTOR pathway by sirolimus was reported as a safe and efficacious treatment option for lymphatic malformations (also known as lymphangiomas). We report the case of a young male patient in which a unilateral, retrobulbar lymphatic malformation regressed to a large extent under treatment with 1 mg sirolimus given orally twice a day over a period of six months.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Orbitárias
/
Sirolimo
/
Linfangioma
/
Antibióticos Antineoplásicos
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article